Triple enzyme block to combat obesity

SlimCarb® assists in the treatment of obesity by inhibiting salivary, pancreatic and intestinal a-glycosidase enzyme activity, thereby promoting a delayed absorption of carbohydrates and glucose. In addition, SlimCarb® has an inhibitory action on pancreatic lipase – an enzyme responsible for digesting fat.

Available on backorder

This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.
WhatsApp chat